These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


136 related items for PubMed ID: 6608972

  • 1. Corticotropin-releasing factor and angiotensin II: comparison of CNS actions to influence neuroendocrine and cardiovascular function.
    Fisher LA, Brown MR.
    Brain Res; 1984 Mar 26; 296(1):41-7. PubMed ID: 6608972
    [Abstract] [Full Text] [Related]

  • 2. Central nervous system effects of corticotropin releasing factor in the dog.
    Brown MR, Fisher LA.
    Brain Res; 1983 Nov 28; 280(1):75-9. PubMed ID: 6606481
    [Abstract] [Full Text] [Related]

  • 3. Differentiated hemodynamic responses to central versus peripheral administration of corticotropin-releasing factor in conscious rats.
    Overton JM, Fisher LA.
    J Auton Nerv Syst; 1991 Jul 28; 35(1):43-51. PubMed ID: 1940026
    [Abstract] [Full Text] [Related]

  • 4. Corticotropin-releasing factor (CRF): central effects on mean arterial pressure and heart rate in rats.
    Fisher LA, Rivier J, Rivier C, Spiess J, Vale W, Brown MR.
    Endocrinology; 1982 Jun 28; 110(6):2222-4. PubMed ID: 6978810
    [No Abstract] [Full Text] [Related]

  • 5. CRF initiates biological actions within the brain that are observed in response to stress.
    Lenz HJ, Raedler A, Greten H, Brown MR.
    Am J Physiol; 1987 Jan 28; 252(1 Pt 2):R34-9. PubMed ID: 3544874
    [Abstract] [Full Text] [Related]

  • 6. Use of ganglionic blockers to assess neurogenic pressor activity in conscious rats.
    Santajuliana D, Hornfeldt BJ, Osborn JW.
    J Pharmacol Toxicol Methods; 1996 Feb 28; 35(1):45-54. PubMed ID: 8645881
    [Abstract] [Full Text] [Related]

  • 7. Corticotropin-releasing factor induces differential behavioral and cardiovascular effects after intracerebroventricular and lateral hypothalamic/perifornical injections in rats.
    Diamant M, Kashtanov SI, Fodor M, de Wied D.
    Neuroendocrinology; 1992 Nov 28; 56(5):750-60. PubMed ID: 1488107
    [Abstract] [Full Text] [Related]

  • 8. GABA agonists inhibit the vasopressin-dependent pressor effects of central angiotensin II.
    Brennan TJ, Morris M, Haywood JR.
    Neuroendocrinology; 1984 Nov 28; 39(5):429-36. PubMed ID: 6514131
    [Abstract] [Full Text] [Related]

  • 9. Modulation of central nervous system actions of corticotropin-releasing factor by dynorphin-related peptides.
    Overton JM, Fisher LA.
    Brain Res; 1989 May 29; 488(1-2):233-40. PubMed ID: 2568150
    [Abstract] [Full Text] [Related]

  • 10. Effect of paraventricular lesions on corticotropin-releasing factor (CRF)-like immunoreactivity in the stalk-median eminence: studies on the adrenocorticotropin response to ether stress and exogenous CRF.
    Bruhn TO, Plotsky PM, Vale WW.
    Endocrinology; 1984 Jan 29; 114(1):57-62. PubMed ID: 6317350
    [Abstract] [Full Text] [Related]

  • 11. Regional hemodynamic responses to central administration of corticotropin-releasing factor (CRF).
    Grosskreutz CL, Brody MJ.
    Brain Res; 1988 Mar 01; 442(2):363-7. PubMed ID: 3259447
    [Abstract] [Full Text] [Related]

  • 12. Pressor, tachycardic and behavioral excitatory responses in conscious rats following ICV administration of ACTH and CRF are blocked by naloxone pretreatment.
    Saunders WS, Thornhill JA.
    Peptides; 1986 Mar 01; 7(4):597-601. PubMed ID: 3020526
    [Abstract] [Full Text] [Related]

  • 13. The effects of naloxone on the cardiovascular and respiratory effects of centrally administered corticotrophin releasing factor in conscious rabbits.
    May CN, Whitehead CJ, Mathias CJ.
    Br J Pharmacol; 1991 Jul 01; 103(3):1776-80. PubMed ID: 1933140
    [Abstract] [Full Text] [Related]

  • 14. Corticotropin-releasing factor (CRF): mechanism to elevate mean arterial pressure and heart rate.
    Fisher LA, Jessen G, Brown MR.
    Regul Pept; 1983 Jan 01; 5(2):153-61. PubMed ID: 6338566
    [Abstract] [Full Text] [Related]

  • 15. Central nervous system actions of corticotropin-releasing factor on cardiovascular function in the absence of locomotor activity.
    Overton JM, Fisher LA.
    Regul Pept; 1989 Jan 01; 25(3):315-24. PubMed ID: 2788898
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Autonomic and cardiovascular effects of corticotropin-releasing factor in the spontaneously hypertensive rat.
    Brown MR, Hauger R, Fisher LA.
    Brain Res; 1988 Feb 16; 441(1-2):33-40. PubMed ID: 2834002
    [Abstract] [Full Text] [Related]

  • 19. [Effect of the corticoliberin fragment CRF(4-6) on blood pressure and heart rate in rats].
    Makarenko EIu, Andreeva LA, Borovik AS, Mart'ianov AA.
    Ross Fiziol Zh Im I M Sechenova; 2005 Jan 16; 91(1):71-9. PubMed ID: 15773582
    [Abstract] [Full Text] [Related]

  • 20. Central nervous system cardiovascular actions of CRF in sinoaortic-denervated rats.
    Overton JM, Davis-Gorman G, Fisher LA.
    Am J Physiol; 1990 Mar 16; 258(3 Pt 2):R596-601. PubMed ID: 2316708
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.